Potential of longitudinal data from single site and multi-center clinical trials for AI-research

Prof. Dr. Hans-Christoph Becker from Stanford University, a long-standing user of mint Lesion™, shares his experience of using the software in this brief interview. He talks about the reaction he received when sharing the mint report for the first time, how patients benefit from the longitudinal overview of disease, and his plans to use the structured data for AI research.

Click here or on the image above to watch the full video on YouTube.

Related Resources

Related Resources

The benefits of structured oncologic reporting with mint Lesion™

Dr. Damiano Caruso of Sapienza Universita di Roma recounts how he got to know mint Lesion™ at a workshop hosted by the ESOI. Among other workstations,…

mint Lesion™ 3.8. Release: What’s New?

The recent 3.8 release brings with it a multitude of new features and refinements that further facilitate reporting, interdisciplinary collaboration,…

SLK Clinics Heilbronn: Oncological Therapy Assessment and Efficient, Structured Reports in Daily Routine

As a clinic group with almost 1500 beds, the SLK Clinics Heilbronn are the largest healthcare provider in the Heilbronn-Franconia region. The clinic…